Curis, Inc. (CRIS)

1.16 -0.13 (-10.08%) USD  |  NASDAQ  |  Dec 12, 16:00
1.21 +0.05 (+4.31%) After-Hours: 06:48
More

Curis EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for CRIS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Agenus, Inc. --
Halozyme Therapeutics, Inc. --
AIM ImmunoTech, Inc. --
Protalix Biotherapeutics, Inc. --
Armata Pharmaceuticals, Inc. --